Tage Carlson Phd, Dabt Email & Phone Number

Libertyville, Illinois

Round Lake, Illinois

Oversaw global organization responsible for toxicologic evaluation and risk assessment of all medical devices, biomaterials, drug formulations and packaging systems. Supported all nonclinical safety aspects of product lifecycle including nonclinical plan development and testing oversight, material biocompatibility strategy, safety assessment of.

Round Lake, IL

Managed Regulatory Toxicology, General Toxicology and Material Testing groups responsible for overall strategy and execution of biocompatibility testing according to ISO 10993 and USP standards. Teams consisted of 30 BS and MS-level colleagues including 4 first-line managers.Skills: Medical Devices, Toxicology, GLP, Biocompatibility, Regulatory.

Abbott Park, IL

Core member of drug development teams, with emphasis on anti-viral and CNS disorder therapies, working across divisions to coordinate and execute preclinical safety plan supporting all phases of drug development. Directed exploratory and GLP toxicology studies across all therapeutic areas, monitored toxicology studies conducted externally, conducted due.

Lafayette, NJ

Core member of drug development teams, working across divisions to coordinate and execute preclinical safety plan. Member of early development teams supporting anti-cancer and anti-viral therapies and late-stage development teams supporting sublingual immunotherapies (SLIT) and anti-inflammatory drugs. Oversaw development of compounds derived both in-house.

Responsible for management and all aspects of the Drug Safety Clinical Pathology laboratory. CAP-accredited and GLP-compliant laboratory consisting of 16 full-time scientists and technicians including one first-line manager. Responsible for hematology, clinical chemistry, urinalysis and coagulation support of all preclinical discovery, preclinical safety.

Responsible for the management of the clinical chemistry section within Drug Safety’s clinical pathology laboratory and the career management of 7 full-time direct reports. Responsible for novel assay development, assay translation from animals to man, new technology validation, and quality control measures. Additional responsibilities included expanded.

Responsible for managing one direct report and the development of novel molecular assays in support of preclinical safety studies. Methodologies included RT-PCR, quantitative PCR, traditional cloning methods, DNA sequencing and Western blotting. Additional responsibilities included summary of clinical pathology data and directing preclinical safety studies.

Phd, Molecular Biology

Thesis Title: Mechanisms of HSF Activity Regulation in Saccharomyces cerevisiae.

B.S., Biology